Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities Source: Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018 Year: 2018
Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Central sleep apnea Source: Respipedia Article Year: 2017
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005
The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019
Shift in sleep apnoea type in heart failure patients in the CANPAP trial Source: Eur Respir J 2010; 35: 592-597 Year: 2010
Relationship between NT-proBNP plasma level and nocturia in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
Day-night pattern of defibrillator shocks in patients with chronic heart failure: The impact of Cheyne-Stokes respiration and obstructive sleep apnoea Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly Source: Eur Respir J 2009; 33: 797-803 Year: 2009
Obstructive sleep apnoea: longer respiratory event lengths in patients with heart failure Source: Eur Respir J 2013; 41: 1340-1346 Year: 2013
Sleep-disordered breathing in the elderly Source: Eur Respir Mon; 2009: 43: 179–204 Year: 2009
Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006
Increased obstructive sleep apnoea (OSA) severity is associated with increased cardiovascular risk, calculated using the RISKSCORE algorithm, and reduced left ventricular function in minimally symptomatic patients Source: Annual Congress 2010 - News from RCT (randomised controlled trials) and epidemiology in sleep apnoea Year: 2010
Symptom burden of sleep-disordered breathing in mild-to-moderate congestive heart failure patients Source: Eur Respir J 2006; 27: 748-755 Year: 2006
Relationship between severity of chronic heart failure (CHF) and sleep related breathing disorders (SRBD) Source: Eur Respir J 2006; 28: Suppl. 50, 815s Year: 2006
Cardiac troponin I levels and relationship with cardiovascular morbidity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005
Are there relationships between apnoea index, nocturnal hypoxaemia, muscle strength and neuromuscular efficiency on sleep apnoea patients (OSAS)? Source: Annual Congress 2009 - Respiratory physiotherapy assessment Year: 2009